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Objective: This study assessed the role of multibranched stent grafts for thoracoabdominal aortic aneurysm (TAAA)
repair.
Methods: Self-expanding covered stents were used to connect the caudally directed cuffs of an aortic stent graft with the
visceral branches of a TAAA in 22 patients (16 men, 6 women) with a mean age of 76  7 years. All patients were unfit
for open repair, and nine had undergone prior aortic surgery. Customized aortic stent grafts were inserted through
surgically exposed femoral (n  16) or iliac (n  6) arteries. Covered stents were inserted through surgically exposed
brachial arteries. Spinal catheters were used for cerebrospinal fluid pressure drainage in 22 patients and for and spinal
anesthesia in 11.
Results: All 22 stent grafts and all 81 branches were deployed successfully. Aortic coverage as a percentage of
subclavian-to-bifurcation distance was 69% 20%.Mean contrast volume was 203mL,mean blood loss was 714mL, and
mean hospital stay was 10.9 days. Two patients (9.1%) died perioperatively: one from guidewire injury to a renal arterial
branch and the other from a medication error. Serious or potentially serious complications occurred in 9 of 22 patients
(41%). There was no paraplegia, renal failure, stroke, or myocardial infarction among the 20 surviving patients. Two
patients (9.1%) underwent successful reintervention: one for localized intimal disruption and the other for aortic
dissection, type I endoleak, and stenosis of the superior mesenteric artery. One patient has a type II endoleak. Follow-up
is >1 month in 19 patients, >6 months in 12, and >12 months in 8. One branch (renal artery) occluded for a 98.75%
branch patency rate at 1 month. The other 80 branches remain patent. There are no signs of stent graft migration,
component separation, or fracture.
Conclusions: Multibranched stent graft implantation eliminates aneurysm flow, preserves visceral perfusion, and avoids
many of the physiologic stresses associated with other forms of repair. The results support an expanded role for this
technique in the treatment of TAAA. (J Vasc Surg 2008;47:6-16.)Large aneurysms of the thoracoabdominal aorta
(TAAA) are at high risk for rupture and death.1 Conven-
tional surgical repair involves wide aortic exposure and
interruption of flow to abdominal organs that have little
tolerance for ischemia. The resultingmortality andmorbid-
ity rates vary with the extent of the disease, the health of the
patient, and the expertise of the center providing care.2-7
Statewide audits provide the best indication of overall
results. In California, for example, the 30-day mortality is
19%, and the 1-year mortality is 31%.2
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6Endovascular technique substitutes transarterial access
for surgical exposure and stent-mediated attachment for
sutured anastomosis, thereby minimizing arterial exposure
and avoiding visceral ischemia. One approach involves a
combination of conventional visceral artery bypass and
conventional stent graft implantation.8-11 An even less
invasive alternative maintains perfusion of the celiac, supe-
rior mesenteric, and renal arteries through multiple
branches of the stent graft.12-18
We report a phase I, single-center, prospective, clinical
study of endovascular aneurysm repair using a modular
multibranched stent graft. In this approach, a large-caliber
primary stent graft arborizes to the visceral arteries through
multiple caudally directed covered stents, and additional
large-caliber components extend the trunk of the stent
graft proximally or distally, depending on the location of
the aneurysm.
METHOD
Study population. The selection criteria are listed
in Table I. Arterial anatomy was assessed using three-
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Mateo, Calif) of fine-cut (3-mm slice thickness) contrast-
enhanced computed tomography (CTA) scans of the chest,
abdomen, and pelvis. The study was conducted under an
Investigational Device Exemption (IDE #G000265) from
the United States Food and Drug Administration (FDA),
as well as under the approval of the Institutional Commit-
tee on Human Research (CHR).
Device design. The primary component of this thora-
coabdominal aortic stent graft system was the cuff-bearing
aortic stent graft, manufactured by Cook-Australia, Inc
(Brisbane, Australia), with two (n 1, 4.5%), three (n 5,
22.7%) or four (n  16, 72.7%) caudally directed cuffs
positioned to correspond to the axial and circumferential
location of the arterial branch on the native aortic aneu-
rysm. This component had a wide proximal segment, a
wide distal segment, and a narrow central, cuff-bearing
segment (Fig 1). Its construction, sterilization, shipping,
and regulatory processing took 6 to 8 weeks.
The entire length of the woven polyester primary aortic
stent graft was supported by a series of stainless steel Z
stents (Fig 1, A). In the latter part of the series, the caudally
oriented barbs of the proximal stent projected through the
graft material. Earlier devices had uncovered proximal
stents. The caudally directed cuffs were 18 mm in length
and 6 to 8 mm in diameter. The celiac cuff was usually one
Table I. Selection criteria
Inclusion
1. Thoracoabdominal aortic aneurysm 6 cm in diameter or 5
cm in diameter and enlarging at a rate of 10 mm/y
2. Anticipated mortality greater than 20% with conventional sur-
gical treatment
3. Life expectancy of 2 years
4. Ability to give informed consent and willingness to comply
with follow-up schedule
5. Suitable arterial anatomy for endovascular repair
Exclusion
1. Free rupture of the aneurysm
2. Pregnancy
3. A history of anaphylactic reaction to contrast material
4. Allergy to nitinol, stainless steel, or polyester
5. Serious systemic or groin infection
6. Uncorrectable coagulopathy
7. Aortic dissection
8. Presence of a dominant artery to the spinal cord arising from
the area of stent graft implantationstent length above the superior mesenteric cuff, which wasusually one stent length above the left renal cuff. The
position of the right renal cuff was more variable. Ra-
diopaque markers on the trunk of the stent graft indicated
overall orientation. Other markers indicated the position of
the proximal and distal ends of each cuff.
More extensive aneurysms required additional compo-
nents. Those involving the proximal aorta (Fig 2) require
unbranched proximal extensions, and those involving the
distal aorta require bifurcated distal extensions. Stent grafts
extensions were sized to ensure an overlap between com-
ponents of at least three stent bodies.
Proximal thoracic extensions were delivered using the
standard Zenith TX-2 (Cook Medical Inc., Bloomington,
Ind) delivery system. Bifurcated aortoiliac stent grafts were
delivered using the standard Zenith delivery system. The
cuff-bearing primary aortic stent graft was delivered
through a modified version of the Zenith fenestrated stent
graft delivery system. Sheath sizes were 20 to 24F (inner
diameter).
The branches of the stent graft consisted of Fluency
covered stents (C. R. Bard, Inc, Tempe, Ariz), measuring
60 mm in length and 7 to 9 mm in diameter, combined
with vascular Wallstents (Boston Scientific Corp, Natick,
Mass), measuring 38 to 39 mm in (nominal) length and 8
to 10 mm in (nominal) diameter.
Device implantation. General anesthesia was used for
12 procedures (54.5%), and a combination of spinal and
local anesthesia was used for 10 (45.5%). Spinal catheters
were inserted for cerebrospinal fluid (CSF) pressure moni-
toring and drainage. Intravenous heparin was given before
arterial puncture, and additional doses were titrated to
maintain an activated clotting time (ACT) 300 seconds.
Although we have sought to standardize our basic
approach, the technique of endovascular TAAA repair re-
mains a work-in-progress. The description that follows
reflects current practice. The procedure had two parts:
transfemoral insertion of the cuffed primary aortic stent
graft and any proximal aortic or distal aortoiliac stent graft
extensions, followed by transbrachial insertion of the cov-
ered stents into the visceral branches.
Step 1. Implantation of cuffed primary aortic stent
graft. The primary aortic stent graft was inserted through
the surgically exposed femoral artery in 16 patients (72.7%)
or through a conduit in six (27.3%) to the common iliac
artery (Fig 3, A). Conduits were most often required to
treat women (50%). Our current practice is to create the
conduit (Fig 3, B) and inert the stent graft at two separate
operations. In this approach, the proximal anastomosis is
end-to-end and the distal anastomosis end-to-side, thereby
avoiding competitive flow and providing a route for retro-
grade flow up the external iliac artery to the internal iliac
artery.
Aortic and aortoiliac stent grafts were inserted over a
stiff guidewire, starting with the most proximal compo-
nents. Standard techniques were used to insert and deploy
the proximal aortic, distal aortic, and distal aortoiliac stent
graft components. Deployment of the cuffed primary aortic
stent graft was more complex because its cuffs had to be
cove
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visceral aortic branches. To minimize the use of contrast,
we substituted selective visceral branch catheterization for
flush aortic injections (Fig 4, A).
In general, we positioned the cuffs 10 to 30 mm above
the corresponding visceral artery orifices. The exact posi-
tion was not critical as long as no cuff was distal to the
corresponding visceral artery orifice. After the sheath was
removed, the constraining wire retained the stent graft in a
partially deployed state, allowing for small adjustments in
the longitudinal position or orientation of the stent graft.
Once a satisfactory position had been achieved, all three
control wires were pulled, the delivery system removed, the
implantation sites balloon-molded, and the stent graft ac-
cess sites repaired, restoring normal lower extremity perfu-
sion.
Step 2. Implantation of covered stents into visceral
branches. We generally used the longest available cathe-
ters, guidewires, and delivery systems (Table II) and tried
to instrument the aortic arch as little as possible. We in-
Fig 1. A,An anterior view of the cuff-bearing segment o
stent graft. C, A Fluency (C. R. Bard, Inc, Tempe, Ariz)serted 10F and 12F coaxial kink-resistant Flexor sheaths(Cook Medical Inc.), one inside the other, over a stiff
guidewire through the surgically exposed right (n  5,
22.7%) or left (n  17, 77.3%) brachial artery, around the
distal aortic arch, and into the descending thoracic aorta.
The 12F sheath was sutured to the skin of the arm once it
was inserted to its fullest extent. In cases of steep subclavian
angulation, we inserted the sheaths over a tensioned
0.035-in brachial-femoral guidewire. This was then ex-
changed for a 0.014-in coronary guidewire (Grand Slam,
Asahi Intec Co, Ltd), which was small enough to share the
lumen of the 10F sheath with a Fluency delivery system
(Fig 4, B).
Each visceral branch was constructed by using the same
series of steps. The most distal branches (renals) were
usually deployed first, and the most proximal (celiac), last.
An angled catheter was directed through the target cuff,
out of the aortic stent graft, across the aneurysm sac, and
into the corresponding target artery (Fig 4, B). Small
volumes of dilute contrast were injected through the selec-
tive catheter to locate the visceral artery orifice, confirm
primary aortic stent graft.B,An internal view of the same
red stent within a cuff of the primary aortic stent graft.f thecatheter position, and define the branching pattern of the
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inserted over a Rosen guidewire (Cook Medical Inc.). The
distal 10 to 20 mm of the 60-mm-long Fluency covered
stent was deployed inside the target artery, and the proxi-
mal 20 to 25mm inside the cuff and the lumen of the aortic
stent graft, leaving approximately 20 mm bridging the
aneurysm. Each covered stent was lined with an oversized
Wallstent to prevent kinking and augment fixation.
A completion angiogram was performed before relin-
quishing wire access into the branch. Deployment of the
celiac branch completed the repair. From then on, CSF
pressure was carefully monitored, and the patient’s lower
extremity motor function was tested at frequent intervals,
depending on the anesthetic technique. We no longer
Fig 2. A, A computed tomography angiography (CTA
aortic aneurysm shows the usual branches to the celiac
carotid-subclavian bypass and endovascular repair of a di
multibranched repair of the thoracoabdominal aorta. Th
flow while lengthening the proximal implantation site.perform a completion flush aortogram because the yield islow and the contrast load high. All wires, sheaths, and
catheters were removed. The brachial artery was repaired,
restoring perfusion to the arm. Anticoagulation was re-
versed, and all wounds were closed.
Postoperative monitoring. All patients spent at least
2 days in the intensive care unit after the operation to
monitor spinal cord function, CSF pressure, and arterial
pressure. We routinely drained 10 mL of CSF hourly dur-
ing the first 12 hours, depending on CSF pressure and
lower extremity neurologic symptoms. If the patient was
neurologically stable, the drain was clamped on the second
postoperative day and removed on the third. We now
withhold most antihypertensive medications, except car-
dioprotective -blockers, for up to 48 hours postopera-
er multibranched repair of a type II thoracoabdominal
erior mesenteric, and renal arteries. B, CTA after left
ch aneurysm, which was performed in conjunction with
a covered stent within the left carotid artery to preserve) aft
, sup
stal ar
ere istively. The goal is to augment spinal cord perfusion.
s a ro
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discharge. Follow-up clinical assessment, laboratory test-
ing, and CTA were performed at 1, 6, and 12 months, and
yearly thereafter. Outcome data were reviewed and re-
ported to the FDA and CHR after every fifth treated
patient.
RESULTS
Between January 2006 and May 2007, 22 patients (16
men, 6 women) with a mean age of 76.2  7.4 years
underwent endovascular TAAA repair using multibranched
stent grafts with caudally oriented cuffs. The mean aneu-
rysm diameter was 67.4  9.3 mm. Nine patients (41%)
had undergone prior aortic surgery. All were considered
unfit for open operation.
The procedural success rate was 100%. Cuffed primary
aortic stent grafts were successfully deployed in all 22
patients, and covered stents were successfully deployed into
81 of 81 target visceral arteries. This represented two of
three branches in one patient, three of three branches in five
patients, and four of four branches in 16 patients. Six of the
seven branches that were not treated were chronically oc-
cluded (1 celiac axis and 5 renal arteries), and one (a renal
artery) was outside the field of repair. The extent of aortic
coverage as a percentage of the distance from the subclavian
artery to the aortic bifurcation was 69%  20%. The mean
estimated blood loss was 714 mL, and the mean contrast
volume was 203 mL. The mean length of hospital stay was
10.9 days.
Two patients (9.1%) died perioperatively. One patient
Fig 3. A, A preoperative computed tomography (CT)
stenosis, and bilateral iliac stenosis. B, A CT scan show
prograde flow to the common femoral artery and (3) retro
iliac artery. Two weeks later, this bypass graft was used asustained a guidewire-induced arterial injury to a distalbranch of her sole renal artery. Coil embolization of the
affected branch appeared to stop the bleeding, and the
operation was completed as planned; however, recurrent
bleeding into the renal capsule caused renal failure, hypo-
tension, and paraplegia. The patient declined dialysis and
died. The other death resulted from the effects of a 50,000
g phenylephrine injection upon arrival in the intensive
care unit. The effects included stroke, myocardial infarc-
tion, low output heart failure, renal failure, and dissemi-
nated intravascular coagulation. Two other patients died
from unrelated causes 6 and 13 months after TAAA repair.
One died of pneumonia, complicating longstanding
chronic obstructive pulmonary disease (COPD), the other
died of sepsis from a decubitus ulcer. Fig 5 shows Kaplan-
Meier plots of survival and freedom from aneurysm-related
death.
Renal failure, myocardial infarction, stroke, and para-
plegia did not occur in any of the 20 patients who survived
TAAA repair. Three patients (13.6%) experienced transient
lower extremity weakness and numbness (paraparesis) dur-
ing periods of hypotension, but none had any residual
neurologic symptoms. Postoperative pneumonia devel-
oped in two patients (9.1%), both of whom had pre-
existent COPD. Table III lists all the serious complications
in this study.
The perioperative period was also notable for striking
hematologic abnormalities. Between the time of operation
and the second postoperative day, the white cell count rose
to 211% of baseline, the platelet count fell to 47% of
baseline, and the INR rose to 120% of baseline. These
hows a right common iliac aneurysm, left common iliac
) right common iliac to external iliac bypass, with (2)
e flow through the external iliac artery to the (4) internal
ute for stent graft insertion.scan s
s a (1
gradeffects correlated with the length of the prosthesis.
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Volume 47, Number 1 Chuter et al 11Fig 4. A, Intraoperative fluoroscopy shows (1) orientation markers, (4) a catheter within the superior mesenteric
artery, and markers at the distal ends of cuffs for branches to the (2) celiac and (3) superior mesenteric arteries. B,
Intraoperative fluoroscopy shows markers at the distal end of the (1) right renal cuff, the (2) tip of a 10F transbrachial
sheath, (3) a tiny (0.014-in) brachial-femoral guidewire, and (4) coils in the smaller (3 mm) of the two renal arteries.
C, Intraoperative angiography shows a branch of the stent graft to the larger (5 mm) of the two right renal arteries.D,
Intraoperative fluoroscopy shows a (1) guidewire with its tip in the splenic artery, (2) markers at the outer end of the
celiac cuff, (3) distal and (4) proximal ends of the undeployed Fluency (C. R. Bard, Inc, Tempe, Ariz) covered stent,
and (5) a marker at the inner end of the celiac cuff.
rior m
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the complications of endovascular TAAA repair. One pa-
tient’s initial CT showed an area of intimal disruption just
above the top the stent graft. An additional stent graft was
implanted to extend the proximal end of the repair and
exclude this lesion from the circulation. Another patient
underwent perioperative (30 days) supplemental stent
graft implantations to treat an iatrogenic type B aortic
dissection. This patient also underwent covered stent im-
Table II. Standard ancillary equipment
Instrument Manufacturer
Fluency covered stent CR Bard
Fluency covered stent CR Bard
Wallstent Boston Scientific
Wallstent Boston Scientific
Vertebral catheter Cook Medical
MPA catheter Cook Medical
C1 catheter Cook Medical
Lunderquist
guidewire
Cook Medical
Glidewire guidewire Terumo Medical
Grand Slam guidewire Asahi Intecc
EN Snare System MDT
Flexor sheath Cook Medical
Flexor sheath Cook Medical
ID, Interior diameter; NA, not applicable; OD, outer diameter; SMA, supe
Fig 5. Kaplan Meier plots of overall survival (diamonds) and
freedom from aneurysm-related death (squares). The dotted line
indicates a standard error 10%.plantation to treat a type 1 endoleak (early), and superiormesenteric angioplasty to treat late (30 days) 70% steno-
sis. These interventions were successful.
Unusual gastrointestinal complications developed in
two patients (9.1%), which greatly delayed their discharge
from the hospital. One had ileus, requiring 4 weeks of
parenteral nutrition. No cause was identified, and bowel
function recovered spontaneously. Another patient sus-
tained an iatrogenic cascade, starting 5 weeks after TAAA
repair with upper gastrointestinal endoscopy for esophageal
achalasia and ending with distal gastrectomy for duodenal
bleeding. His eventual recovery was delayed by postopera-
tive pneumonia.
Hydrocephalus developed in one patient a week after
stent graft implantation, requiring placement of a tempo-
rary ventricular drain. The presumed cause was intrathecal
bleeding at the spinal catheter insertion site.
Only two patients (9.1%) have had an endoleak at any
point in their follow-up. The sole type 1 endoleak was
eliminated, as already described. Another patient has a type
2 endoleak, and its management will be dictated by aneu-
rysm behavior. Both endoleaks were visible on the first
postoperative CT.
Of the 22 patients in this series, 19 have been followed
up for 1 month, 12 for 6 months, and 8 for 12
months. There are no signs of stent graft migration, com-
ponent separation, or fracture. One renal artery occluded
within a month of implantation. The other 80 branches
(98.8%) remain patent according to the most recent fol-
low-up CT. During the 1- to 6-month follow-up interval,
two patients presented with short-segment stenosis just
downstream from the distal end of the covered stent. In one
case (described above), an area of stenosis in the superior
Length,
cm Sheath size
Device
dimensions
117 9F (OD) 7  60 mm
(renal)
117 9F (OD) 9  60 mm
(celiac,
SMA)
125 7F (OD) 8  38 mm
(renal)
125 7F (OD) 10  39 mm
(celiac,
SMA)
125 5F (OD) NA
100 5F (OD) NA
65 5F (OD) NA
260 NA 0.035 in
260 NA 0.035 in
300 NA 0.014 in
NA NA 27-45 mm
80 10F (ID) 12F (OD)
40 12F (ID) 14F (OD)
esenteric artery.mesenteric artery was treated with balloon dilatation and
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stenosis of the renal artery was left untreated.
DISCUSSION
There is good reason to seek a less invasive endovascu-
lar alternative to the open surgical repair of TAAA. Al-
though individual high-volume centers report good out-
comes, mortality and morbidity rates vary widely,
depending on the health of the patient, the extent of the
aneurysm, the skill of the surgeon, and the quality of the
perioperative care.4-7 Statewide audits2,3 provide a sober-
ing picture of the overall experience.
Endovascular techniques long ago assumed a promi-
nent role in the management of aneurysms isolated to the
descending thoracic and infrarenal abdominal segments of
the aorta. The same would be true of the intervening
Table III. A patient-by-patient listing of complications
Patient
Complication
Perioperative
Late (30
days)
1 Pneumonia None
2 None None
3 Renal failure N/A
Paraplegia
Death
4 Renal occlusion None
5 None None
6 None None
7 None None
8 None None
9 None None
10 Aortic dissection SMA stenosis
Type I endoleak
11 Pneumonia None
12 None None
13 Transient paraparesis None
14 Transient paraparesis None
15 Transient paraparesis None
16 Ileus None
Catheter sepsis
CHF
HIT
17 None None
18 None None
19 Stroke N/A
MI
Pulmonary failure
Extremity ischemia
Death
20 Aortic dissection None
Achalasia None
GI bleeding
Pneumonia
MI
21 None None
22 Subarachnoid bleed None
Hydrocephalus
Stroke
CHF, Congestive heart failure; GI, gastrointestinal;HIT, heparin induced th
mesenteric artery; VP, ventriculoperitoneal.
*By computed tomography scan at death or latest follow-up.thoracoabdominal segment were it not for the complexitiesinvolved in excluding the aneurysm from the circulation
while maintaining flow to its branches.
One widely practiced approach combines open surgical
bypass to the visceral arteries with endovascular exclusion
of the aneurysm.8-11 The hybrid surgical/endovascular
procedure substitutes laparotomy for thoracoabdominal
exposure, eliminates aortic mobilization and clamping, and
reduces the duration of visceral ischemia, all of which
should reduce morbidity and mortality. This method is
widely applicable because both parts of the operation in-
volve standard techniques and readily available stent grafts.
The disappointing results in some series reflect the fact that
visceral bypass still constitutes a large operation for this
high-risk population.
The first branched stent grafts were of a unibody de-
sign, with the branches sutured to the primary stent graft.18
Reintervention Aneurysm status
Branch
status
None No endoleak 4/4 patent
None No endoleak 4/4 patent
None No data No data
None No endoleak 3/4 patent
None No endoleak 4/4 patent
None No endoleak 3/3 patent
None No endoleak 4/4 patent
None No endoleak 2/2 patent
None No endoleak 4/4 patent
Stent graft No endoleak 4/4 patent
Covered stents
Stent SMA
None No endoleak 4/4 patent
None No endoleak 4/4 patent
None No endoleak 4/4 patent
None No endoleak 3/3 patent
None No endoleak 4/4 patent
None No endoleak 4/4 patent
None No endoleak 4/4 patent
None No endoleak 4/4 patent
None No data No data
Stent graft No endoleak 4/4 patent
Laparotomy
None Type II endoleak 4/4 patent
VP shunt No endoleak 4/4 patent
ocytopenia;MI,myocardial infarction;N/A, not applicable; SMA, superiorrombThe entire multibranched stent graft was inserted as a single
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ters. The inherent complexity of this approach has limited
its application to a small number of single and double-
branched repairs.
Modular stent grafts are assembled in situ from multi-
ple components. All current multibranched modular stent
grafts combine large-caliber self-expanding stent grafts
with small-caliber covered stent branches.12-17 They differ
in the type of intercomponent connection. Our technique
involves an overlapping connection between a self-expand-
ing covered stent and a caudally directed cuff attached to
the primary stent graft. Other designs have no overlap, just
a ring of contact between a balloon-expanded covered stent
and the margin of a hole (fenestration) in the stent graft. In
the fenestrated approach, the branches emerge from the
primary stent graft in a transaxial plane. This orientation
provides little latitude for misalignment between the fenes-
tration and the target artery and little resistance to displace-
ment from caudally directed forces.
Many authors have combined fenestrations, fenestrated
branches, and cuffed branches within a single device.12-15
We have found such combinations cumbersome. Fenestra-
tions depend on direct contact between the aorta and the
stent graft,19 whereas cuffed branches require a space be-
tween the aorta and the stent graft. As a result, fenestrated
stent grafts tend to be wide and cuffed stent grafts tend to
be narrow. The two are difficult to combine unless they are
far enough apart to permit a significant change in stent graft
diameter.
The potential advantages of an all endovascular ap-
proach are obvious: No body cavities are opened, no
large arteries are clamped, and no organs are rendered
ischemic. In theory, the endovascular procedure imposes
less stress on the patient, which should translate into less
mortality, morbidity, and debility. The rate of serious
complications in this series was relatively low, consider-
ing that many of these high-risk patients had extensive
aneurysms, yet their recovery was slower than one might
expect given the limited nature of the surgical insult. All
were affected by some combination of fever, leukocyto-
sis, anorexia, malaise, thrombocytopenia, and coagu-
lopathy. These are common findings after standard en-
dovascular repair of abdominal and thoracic aortic
aneurysms,20,21 but the effects are usually mild. Perhaps
the severity of the inflammatory response in this series
reflects the extent of the repair or some specific charac-
teristic of the technique. A pronounced inflammatory
response is certainly not unique to the endovascular
method of TAAA repair,22 just more noticeable.
Unsuitable arterial anatomy was a relatively uncommon
reason for exclusion from this series. The study group
contained examples of stenosis, angulation, and aneurysm
of the renal artery (Fig 6); stenosis and angulation of the
celiac artery; aneurysm of the common iliac artery (Fig 3,
A); aneurysm of the distal aortic arch (Fig 2, B); stenosis
and tortuosity of the iliac arteries (Fig 3, A); and tortuosity
of the aorta (Fig 7).Endovascular repair is feasible in most TAAAs. The
issue is not who can be treated this way, but who should be
treated this way. Perhaps the best candidate for endovascu-
lar repair is a patient with an extensive TAAA (type II or
III), previous aortic surgery, and an otherwise normal life
expectancy. Other patients stand to benefit less. High-risk
patients are more likely to die of cardiac disease than of
aneurysm rupture,23 whereas low-risk patients with type IV
TAAA often do quite well with open surgery.4-6
Before endovascular repair can assume a prominent role
in the management of any subgroup of TAAA cases, the
necessary skills and technology will have to become more
widely available. Access to the device is currently limited by
cost, regulatory constraints, and delays in manufacture.
One of the commoner exclusion criteria among candidates
for this study was the presence of symptoms that precluded
a long delay. The interval between device design and oper-
ation was never less than 6 weeks. In some cases, it might be
possible to eliminate this delay by choosing from a range of
standard, premade components. The modular approach
helps to limit the required inventory, because proximal and
distal extensions can accommodate much of the variation in
the size and location of the proximal and distal implanta-
tion sites, and the covered stents can accommodate much
of the variation in the distribution of renal and splanchnic
arteries.
During the past 7 years, we have performed endovas-
cular TAAA repair using variousmultibranched stent grafts,
combining external cuffs, internal cuffs, and fenestrations
(no cuffs) with balloon-expanded and self-expanding stent
grafts.Many design features of the current stent graft reflect
Fig 6. A preoperative computed tomography scan shows the
aneurysm, stenosis, and angulation of the left renal artery and
severe stenosis of the right renal artery.the lessons of this experience. For example, we found long
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difficult to deploy accurately; hence, the use of multiple
overlapping aortic and aortoiliac components. A reduction
in the bulk of the cuff-bearing component was an incidental
benefit. The narrow waist of the current primary cuff-
bearing component also had a volume-reducing effect.
More important, the narrow waist provided space around
the stent graft for flow to the visceral arteries during stent
graft deployment. As the device evolved, so did the opera-
tion. Features such as coaxial kink-resistant sheaths, stiff
J-tip wires, and brachial-femoral wires were first used to
treat specific anatomic distortions and subsequently incor-
Fig 7. A postoperative computed tomography scan shows a tor-
tuous stent graft within a tortuous aorta.porated into the standard technique.CONCLUSION
We would be the first to admit that there is a lot still to
learn about this new method of TAAA repair. The results
will almost certainly improve as the approach matures fur-
ther, yet our experience suggests that multibranched stent
graft implantation is already safe, effective, and applicable in
a high proportion of cases. If this form of repair proves to be
durable, the technique should assume a prominent role in
the management of TAAA, especially for patients with
extensive aneurysms who fare poorly after conventional
open surgery.
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